|
Hexamethyldisilazane (HMDS) can form Nitrosamine Impurity?
|
|
7
|
594
|
October 29, 2024
|
|
Primeros pasos para evaluar nitrosaminas en medicamentos
|
|
5
|
268
|
September 23, 2024
|
|
N-Nitroso Carbidopa
|
|
2
|
491
|
September 12, 2024
|
|
Can API with amide should considered a potential candidate for forming nitrosamine impurity
|
|
5
|
604
|
September 12, 2024
|
|
Potential Topic for an event concerning obtaining the right level of Nitrosamine Risk Assessment information from your CMOs
|
|
22
|
1697
|
September 5, 2024
|
|
How much Amine and Nitrating agent "Stoichiometric Ratio" required for formation of Nitrosamine impurities?
|
|
3
|
315
|
August 28, 2024
|
|
DMF in API, specification limit in formulation
|
|
5
|
843
|
August 26, 2024
|
|
Nitrosamine impurities of related substances of API's
|
|
7
|
945
|
August 12, 2024
|
|
N-nitroso Omeprazole
|
|
4
|
1766
|
August 3, 2024
|
|
Control limit of Nitrosamines and N-nitroso compounds
|
|
2
|
494
|
July 8, 2024
|
|
Non-mutagenic, carcinogenic impurities
|
|
3
|
668
|
June 30, 2024
|
|
Tetrazole nitrosamines
|
|
1
|
302
|
June 13, 2024
|
|
Update: EFPIA workflows for Quality Risk management Jun 2024 v03
|
|
2
|
1217
|
June 4, 2024
|
|
AI limit of API having very law MDD
|
|
1
|
364
|
May 27, 2024
|
|
Category 5 NDSRIs- CPCA tool
|
|
2
|
543
|
May 20, 2024
|
|
Nitrosamine in Azathioprine
|
|
4
|
918
|
May 14, 2024
|
|
APIC NA Risk Assessment Template
|
|
5
|
4021
|
May 11, 2024
|
|
Risk Analysis for Ergotamine Tartrate
|
|
4
|
449
|
April 22, 2024
|
|
Nitrosamines: A new systematic review
|
|
8
|
3405
|
April 13, 2024
|
|
AI Limit for Nitroso Nebivolol
|
|
11
|
2879
|
April 3, 2024
|
|
AI difference between FDA and EMA, HC and TGA
|
|
0
|
1218
|
March 22, 2024
|
|
Nitroso amines quantification in drugs which are having MDD Value more than 10.0g/Day
|
|
2
|
456
|
March 20, 2024
|
|
New Validated LC-MS Method Development and Estimation of Nitrosamine impurities in Canaglifozin -Pub
|
|
0
|
842
|
February 16, 2024
|
|
N- nitroso Nitazoxanide
|
|
1
|
562
|
February 8, 2024
|
|
Reflective Beginnings: We have to be in the driver's seat
|
|
4
|
565
|
January 9, 2024
|
|
Redefining Nitrosamine Risks: A Fresh Perspective on Pharmaceuticals -Pub
|
|
16
|
2596
|
December 17, 2023
|
|
Quantification of 13 N-Nitrosamines in Pharmaceuticals using SPE-LC-MS/MS
|
|
0
|
1092
|
December 13, 2023
|
|
MDD for API/DP for Ophthalmic Formulation
|
|
4
|
1166
|
December 12, 2023
|
|
10º encontro Farmacopeia Brasileira
|
|
0
|
530
|
November 30, 2023
|
|
Does atmospheric NO2 influence the formation of NDMA in metformin?
|
|
2
|
636
|
November 3, 2023
|